Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer
S. Zhong, C. R. Fields, N. Su, Y. X. Pan, K. D. Robertson
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer'. Together they form a unique fingerprint.